The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 23, 2015

Filed:

Sep. 08, 2009
Applicants:

Thomas P. Quinn, Columbia, MO (US);

Natalia G. Karasseva, Columbia, MO (US);

Inventors:

Thomas P. Quinn, Columbia, MO (US);

Natalia G. Karasseva, Columbia, MO (US);

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 49/00 (2006.01); G01N 33/574 (2006.01); G01N 33/74 (2006.01); A61K 49/10 (2006.01); A61K 33/24 (2006.01); A61B 5/00 (2006.01); A61K 51/08 (2006.01); A61K 38/08 (2006.01);
U.S. Cl.
CPC ...
A61K 49/0002 (2013.01); A61K 49/10 (2013.01); A61K 33/245 (2013.01); A61B 5/0071 (2013.01); A61K 51/088 (2013.01); A61K 38/08 (2013.01); A61K 49/0045 (2013.01); G01N 33/57492 (2013.01); G01N 33/74 (2013.01);
Abstract

The ErbB-2 receptor, a member of the tyrosine kinase type 1 family of receptors, has been implicated in many human malignancies. Bacteriophage display technology was employed to identify peptides that bound to the extracellular domain of human ErbB-2. The peptide KCCYSL, most frequently occurring in the affinity selected population, was chemically synthesized and characterized for its binding activities to the recombinant extracellular domain of ErbB-2. The synthetic peptide exhibits high specificity to ErbB-2 as well as to ErbB-1, another member of ErbB family. Thus, this peptide can be employed in cancer imaging or therapeutic agent targeting to malignant cells ErbB-2 receptor.


Find Patent Forward Citations

Loading…